AN2 TherapeuticsANTX
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 38 institutions reported holding AN2 Therapeutics Inc. (ANTX) in their 13F filings, unchanged from Q4 2024. 5 opened new positions and 5 sold out. The largest holders were BML Capital Management, LLC ($7.8M), Almitas Capital LLC ($1.8M) and Vanguard Group Inc. ($1.4M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- AN2 Therapeutics Inc.
- CUSIP
- 037326105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $151K |
| Exits | 5 | $613K |
All 13F filers, Q4 2024 → Q1 2025: 959,275 shares bought and 1,147,375 shares sold, net −188,100 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 38 holders
| BML Capital Management, LLC | 6.33% | No change | 5,749,432 | $7.8M |
| Almitas Capital LLC | 0.59% | No change | 1,313,111 | $1.8M |
| Vanguard Group Inc. | 0.00% | No change | 1,035,947 | $1.4M |
| Adage Capital Partners Gp, L.L.C. | 0.00% | Add +219.9% | 1,000,000 | $1.4M |
| Pfizer Inc | 0.19% | No change | 715,295 | $973K |
| Peapod Lane Capital LLC | 0.89% | Add +0.3% | 580,853 | $790K |
| Bank of Nova Scotia | 0.00% | Add +16.3% | 459,194 | $625K |
| Two Sigma Advisers, LP | 0.00% | Reduce -15.8% | 445,004 | $605K |
| Bank of Montreal | 0.00% | No change | 422,077 | $574K |
| Aldebaran Capital, LLC | 0.52% | Add +18.3% | 406,623 | $553K |
| Bank of America Corp. | 0.00% | Add +0.0% | 385,483 | $524K |
| Renaissance Technologies | 0.00% | Reduce -36.4% | 368,708 | $501K |
| Two Sigma Investments, LP | 0.00% | Reduce -14.1% | 343,960 | $468K |
| BlackRock, Inc. | 0.00% | Reduce -0.2% | 300,686 | $409K |
| Geode Capital Management, LLC | 0.00% | Add +11.5% | 253,923 | $345K |
| UBS Group AG | 0.00% | Reduce -37.7% | 106,021 | $144K |
| State Street Corp. | 0.00% | No change | 87,002 | $118K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -63.1% | 59,900 | $81K |
| Millennium Management | 0.00% | Reduce -76.1% | 50,038 | $68K |
| Rangeley Capital, LLC | 0.08% | New | 50,000 | $68K |
| Northern Trust Corp. | 0.00% | No change | 43,196 | $59K |
| Integrated Wealth Concepts LLC | 0.00% | No change | 25,000 | $34K |
| Lepercq De Neuflize Asset Management LLC | 0.03% | New | 23,234 | $32K |
| Private Advisor Group, LLC | 0.00% | No change | 22,500 | $31K |
| Schonfeld Strategic Advisors LLC | 0.00% | Reduce -25.2% | 20,115 | $27K |
| Inspirion Wealth Advisors, LLC | 0.00% | New | 18,950 | $26K |
| Jane Street Group, LLC | 0.00% | New | 18,131 | $25K |
| Federated Hermes, Inc. | 0.00% | Add +63.3% | 12,237 | $17K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -0.0% | 10,184 | $14K |
| Captrust Financial Advisors | 0.00% | Reduce -65.1% | 10,000 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +42.3% | 2,082 | $3K |
| Innovative Advisory Group, LLC | 0.00% | No change | 1,170 | $2K |
| Coldstream Capital Management Inc. | 0.00% | New | 783 | $1K |
| BNP Paribas Financial Markets | 0.00% | No change | 312 | $424 |
| Morgan Stanley | 0.00% | No change | 300 | $408 |
| Osaic Holdings, Inc. | 0.00% | No change | 300 | $408 |
| SBI Securities Co., Ltd. | 0.00% | No change | 200 | $272 |
| JPMorgan Chase & Co. | 0.00% | Reduce -5.8% | 49 | $67 |
"% of holder's portfolio" is ANTX's weight in each manager's 13F, not the share of AN2 Therapeutics Inc. the manager owns.